• Bookmarks
    • Add bookmark
  • Login
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact
Close
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact

All Posts

HomeBlogAll Posts

Nanoparticles against cancer in the Live Research Fair

16 May, 2017 1093
Nanoparticles against cancer in the Live Research Fair

Can we improve the treatment of cancer with the help of nanoparticles? How can we help improve the effectiveness of a drug? Which treatment works best? And how can we test it? These are some of the questions that the group if Functional...

Read more

Diverse Applications of Nanomedicine.

28 March, 2017 1083

Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, Bosi S, Carril M, Chan WC, Chen C, Chen X, Chen X, Cheng Z, Cui D, Du J, Dullin C, Escudero A, Feliu N, Gao M, George M, Gogotsi...

Read more

Effect of agitation in magneto-assay performance

19 March, 2017 969

G. Ruiz-Vega, E. Baldrich. Sensors and Actuators B: Chemical , 247, 718–726.   http://www.sciencedirect.com/science/article/pii/S092540051730494X Magnetic particles (MP) are extensively used to improve immunocapture and immunodetection...

Read more

Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.

6 March, 2017 827

Mateo-Lozano S, Bazzocco S, Rodrigues P, Mazzolini R, Andretta E, Dopeso H, Fernandez Y, Del Llano E, Bilic J, Suarez-Lopez L, Macaya I, Carton-Garcia F, Nieto R, Jimenez-Flores LM, de Marcondes PG, Nunez Y, Afonso E, Cacci K, Hernandez-Losa J...

Read more

Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer

7 February, 2017 792

Andretta E, Carton-Garcia F, Martinez-Barriocanal, de Marcondes PG, Jimenez-Flores LM, Macaya I, Bazzocco S, Bilic J, Rodrigues P, Nieto R, Landolfi S, Ramon Y Cajal S, Schwartz S, Brown A, Dopeso H, Arango D Sci Rep. 2017 Feb 7;7:41576...

Read more

Unmet needs in developing nanoparticles for precision medicine

6 February, 2017 1072

Schwartz S Jr Nanomedicine (Lond). 2017 Feb;12(4):271-274. doi: 10.2217/nnm-2016-0390. Epub 2017 Jan 17. https://www.ncbi.nlm.nih.gov/pubmed/?term=28093937  

Read more

Nonclinical Evaluation of the New Topical Hemostatic Agent TT-173 for Skin Grafting Procedures.

31 January, 2017 920

Codina SR, Herance JR, Centeno A, Valero J, Arias B, Miquel I, Sánchez P, Rincón E, López R, Murat J. J Burn Care Res. 2017 Jan 31. doi: 10.1097/BCR.0000000000000497 https://www.ncbi.nlm.nih.gov/pubmed/?term=28157787 Abstract Blood loss during...

Read more

Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona.

18 January, 2017 729

Piella J, Bastús NG, Puntes V. Bioconjug Chem. 2017 Jan 18;28(1):88-97. doi: 10.1021/acs.bioconjchem.6b00575. Epub 2016 Dec 20. https://www.ncbi.nlm.nih.gov/pubmed/?term=27997136 Abstract Surface modifications of highly monodisperse...

Read more

Ultrasound functional evaluation of fetuses with myelomeningocele: study of the interpretation of results.

16 January, 2017 775

Maroto A, Illescas T, Melendez M, Arevalo S, Rodo C, Peiro JL, Belfort M, Cuxart A, Carreras E J Matern Fetal Neonatal Med. 2017 Jan 16:1-5. doi: 10.1080/14767058.2016.1247262. https://www.ncbi.nlm.nih.gov/pubmed/27997256?dopt=Abstract  ...

Read more

Tumour cells are dependent on fat to start metastasis

14 December, 2016 1359
Tumour cells are dependent on fat to start metastasis

A study headed by Salvador Aznar Benitah, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona), and published today in Natureidentifies metastasis-initiating cells through a specific marker, namely the protein CD36. This...

Read more

Design of chalcogen-containing norepinephrines: efficient GPx mimics and strong cytotoxic agents against HeLa cells

8 December, 2016 835

Marset A, Begines P, López Ó, Maya I, García-Aranda N, Schwartz S Jr, Abasolo I, Fernández-Bolaños JG. Future Med Chem. 2016 Dec;8(18):2185-2195. Epub 2016 Nov 15. https://www.ncbi.nlm.nih.gov/pubmed/27845568 Abstract AIM: Numerous chronic...

Read more

VHIR participates in a European project against Fabry disease

23 November, 2016 1226
VHIR participates in a European project against Fabry disease

The Drug Delivery and Targeting group from the CIBBIM-Nanomedicine at VHIR, led by Dr. Simó Schwartz Jr., participates in a new European project, which aims the innovation and improvement in the treatment for Fabry disease, a rare condition...

Read more
…45678…11-20
Search
Categories
  • About-us
  • Biomedical Research in Digestive Tumors
  • Drug Delivery and Targeting
  • events
  • Immune Regulation and Immunotherapy Group
  • Kidney Physiopathology
  • New Technologies and Craniofacial Microsurgery
  • News
  • Pharmacokinetic Nanoparticles
  • Publications
  • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
  • Uncategorized
Recent Posts
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
30 September, 2020by CIBBIM - Nanomedicine0
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
24 February, 2020by CIBBIM - Nanomedicine0
Tags
CLINICAL APPLICATION OF NANOMEDICINE ESNAM EUROPEAN SOCIETY FOR NANOMEDICINE INTERNATIONAL SOCIETY OF NANOMEDICINE ISN
Contact Us
CIBBIM-Nanomedicine
Institut de Recerca
Hospital Universitari Vall d'Hebron
Passeig Vall d'Hebron, 119-129-
08035 Barcelona - Spain
Tel: +34 93 489 4055
Fax: +34 93 489 4040
  • Email: info@cibbim.eu


CIBBIM-Nanomedicine laboratories are located within VHIR’s premises (Mediterrània and Collserola buildings, in violet), Bus lines and Metro stations (Line Green (L3); stops of Montbau and Vall d’Hebron) are also indicated.

ACCESS MAP LOCAL
Albertino © 2014 All Rights Reserved
Forgot password?
You can login using your social profile
Problem with login?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More